Asit Parikh

This profile gathers the share dealings of Asit Parikh in Phathom Pharmaceuticals, Inc., where the filings describe the role as board member. Over a trading history stretching from 12 May 2022 to 10 March 2026, the count stands at 17 filings.

Every open-market trade on record is a purchase: 8 purchases worth €309k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 share grants and 3 option exercises.

In size, the median ticket on the buying side is €34k. On 3 out of 8 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 11 March 2026, the filings show a transaction in Phathom Pharmaceuticals, Inc. The most recent open-market purchase was published on 8 May 2025, 531 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.